Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma Salvadó

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|May 28, 2026
Blood biomarkers for Alzheimer's disease: from detection to decisionsMarc Suárez-Calvet, Gemma Salvadó, Beatriu Bilbeny de Fortuny, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Trajectories of plasma biomarkers, amyloid-beta burden and cognitive decline in Alzheimer's disease: A Longitudinal ADNI StudyYara Yakoub, Ting Qiu, Clémence Peyrot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 10, 2025
Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic reviewClàudia Porta-Mas, Oriol Grau-Rivera, Juan Domingo Gispert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2021
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementiaGemma Salvadó, Michel J Grothe, Colin Groot, et al.
Acta Neuropathologica Communications|June 30, 2025
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohortDivya Bali, Gemma Salvadó, Thomas G Beach, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 9, 2021
Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individualsLyduine E Collij, Sophie E Mastenbroek, Gemma Salvadó, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Brain : a Journal of Neurology|January 16, 2025
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-betaClaudia Cicognola, Gemma Salvadó, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|May 28, 2026
Blood biomarkers for Alzheimer's disease: from detection to decisionsMarc Suárez-Calvet, Gemma Salvadó, Beatriu Bilbeny de Fortuny, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Trajectories of plasma biomarkers, amyloid-beta burden and cognitive decline in Alzheimer's disease: A Longitudinal ADNI StudyYara Yakoub, Ting Qiu, Clémence Peyrot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 10, 2025
Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic reviewClàudia Porta-Mas, Oriol Grau-Rivera, Juan Domingo Gispert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2021
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementiaGemma Salvadó, Michel J Grothe, Colin Groot, et al.
Acta Neuropathologica Communications|June 30, 2025
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohortDivya Bali, Gemma Salvadó, Thomas G Beach, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 9, 2021
Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individualsLyduine E Collij, Sophie E Mastenbroek, Gemma Salvadó, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Brain : a Journal of Neurology|January 16, 2025
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-betaClaudia Cicognola, Gemma Salvadó, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Pageof 11